1. Home
  2. MLYS vs EPAC Comparison

MLYS vs EPAC Comparison

Compare MLYS & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$31.07

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Enerpac Tool Group Corp.

EPAC

Enerpac Tool Group Corp.

HOLD

Current Price

$42.27

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
EPAC
Founded
2019
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MLYS
EPAC
Price
$31.07
$42.27
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$47.33
$50.50
AVG Volume (30 Days)
1.2M
336.3K
Earning Date
02-12-2026
03-23-2026
Dividend Yield
N/A
0.09%
EPS Growth
N/A
0.98
EPS
N/A
1.66
Revenue
N/A
$615,911,000.00
Revenue This Year
N/A
$5.62
Revenue Next Year
N/A
$5.43
P/E Ratio
N/A
$25.55
Revenue Growth
N/A
3.91
52 Week Low
$8.24
$35.01
52 Week High
$47.65
$47.47

Technical Indicators

Market Signals
Indicator
MLYS
EPAC
Relative Strength Index (RSI) 44.90 60.44
Support Level $28.17 $41.16
Resistance Level $31.83 $42.99
Average True Range (ATR) 1.67 1.07
MACD 0.11 0.15
Stochastic Oscillator 48.77 83.25

Price Performance

Historical Comparison
MLYS
EPAC

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision hydraulic and mechanical tools, controlled-force products, and heavy lifting solutions. Operating mainly through its Industrial Tools & Services (IT&S) segment, the company designs, manufactures, and distributes branded tools, and offers maintenance, bolting, machining, joint integrity, and equipment rental services across industries such as oil & gas, manufacturing, power generation, and infrastructure. Its key products include hydraulic cylinders, pumps, torque wrenches, and bolt tensioners under the brands ENERPAC and HYDRATIGHT. The company serves customers internationally, with operations in the USA, Australia, Brazil, Germany, Saudi Arabia, the United Kingdom, and other countries, deriving the majority of its revenue from the USA.

Share on Social Networks: